focus -WSS

focus

author：knowledge 2025-08-26 23:48:40 - browse：386

What difference does a day make? Who gets to have gene therapy? And are biotech startups OK?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to explain how the approval of a landmark gene therapy for Duchenne muscular dystrophy set in motion a frantic race to get children treated before their 6th birthdays. Then, HSBC Managing Director Jonathan Norris calls in to discuss why so many biotech startups are facing financial bridges to nowhere.

For more on what we cover, here’s the story on gene therapy; here’s more on Ipsen’s treatment for FOP; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Medicare explains how it will choose drugs for negotiation

focus

WSS

A controversial new treatment promises to make little people taller

2 officers injured in shooting in Orlando, police say

Physicians aren't 'burning out.' They're suffering from moral injury

H.R. 3 is the wrong path to lower drug costs

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Medicare explains how it will choose drugs for negotiation

leisure time

focus

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

H.R. 3 is the wrong path to lower drug costs

DIEP, the 'gold standard' of breast reconstruction, is under threat

How a symptom of dementia informs our understanding of creativity

Sports medicine is finally prioritizing gender equality

Winners, losers from Medicare’s list of drugs subject to price talks

New air purifier tech could be key to improving indoor air quality

Winners, losers from Medicare’s list of drugs subject to price talks

BioMarin wins approval for gene therapy to treat hemophilia A

How to make AI work for medicine

Wikipedia

Alnylam reports growth in sales of rare disease treatments

Physicians aren't 'burning out.' They're suffering from moral injury

How to ethically and practically extend health care to all

Departing Stanford president retracts two papers

How Long Island became the ‘eugenics capital of the world’

Heart disease in astronauts blamed on cosmic radiation

focus

entertainment

focus

focus